News

DDT metabolite may be associated with risk for Alzheimer’s

Posted on: 27/01/2014 - 21:00

A metabolite of the pesticide DDT – banned in the United States since 1972 – was associated with late-onset Alzheimer’s disease in a small, case-control study. Levels of the chemical...

Field of Interest: Geriatrics

Type: News Item

Sound Off: How do you determine the appropriate interval for follow-up visits?

Posted on: 24/01/2014 - 21:20

Total United States health care costs could be lowered by billions of dollars per year if evidence-based guidelines for follow-up patient visits are established, according to the authors of a <link...

Field of Interest: Cardiology

Type: News Item

Immunosuppressive therapy ups risk for skin cancers

Posted on: 23/01/2014 - 20:48

HOLLYWOOD, FLA. – Current and previous use of thiopurines, biologics, and combination therapies are all independent risk factors for skin cancer, according to expert analysis given at a conference on inflammatory bowel diseases. Although population-based cohort studies have shown that the baseline... more

Field of Interest: Gastroentero...

Type: News Item

One health system cut diabetes events, with set patient measures and cash for physicians

Posted on: 23/01/2014 - 19:30

An incentivized, system-based approach to improve care for patients with diabetes and other chronic diseases appeared to pay off after just 3 years by significantly cutting the incidence of adverse...

Field of Interest: Endocrinology

Type: News Item

Immunosuppressive therapy ups risk for skin cancers

Posted on: 23/01/2014 - 14:35

Field of Interest: Gastroentero...

Type: News Item

Two Alzheimer’s immunotherapy drugs flunk in four studies

Posted on: 22/01/2014 - 22:00

Two investigational Alzheimer’s immunotherapies failed to show any benefit in a series of phase III trials comprising more than 4,000 patients. Neither bapineuzumab, which targets soluble and...

Field of Interest: Geriatrics

Type: News Item

Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD

Posted on: 22/01/2014 - 18:40

HOLLYWOOD, FLA. – The benefits of short-term trial immunosuppressive therapy outweigh the risks in inflammatory bowel disease, but certain patient populations require more vigilance than others, Dr....

Field of Interest: Gastroentero...

Type: News Item

MicroRNA screening might reveal pancreatic cancer

Posted on: 21/01/2014 - 22:20

Researchers have identified two novel panels of microRNAs that eventually might be used to screen patients for pancreatic cancer, distinguishing affected patients from healthy individuals and from...

Field of Interest: Endocrinology

Type: News Item

The price and cost of hepatitis C treatment

Posted on: 16/01/2014 - 19:55

Chronic hepatitis C virus (HCV) infection is a major cause of liver disease affecting 180 million people globally. HCV infection, both silent and slow in its revelation, and devastating in its...

Field of Interest: Gastroentero...

Type: News Item

Dual-vaccine therapy prolonged survival in pancreatic cancer

Posted on: 16/01/2014 - 18:35

SAN FRANCISCO – Serial administration of two vaccines that stimulate the immune response to pancreatic cancer antigens prolonged survival of metastatic disease by about 2 months, according to Dr....

Field of Interest: Gastroentero...

Type: News Item

Newsletters

Stay informed on our latest news!

You are here

Newsletters

Latest Newsletters